Your browser doesn't support javascript.
loading
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial.
Verma, Subodh; Mazer, C David; Fitchett, David; Inzucchi, Silvio E; Pfarr, Egon; George, Jyothis T; Zinman, Bernard.
Affiliation
  • Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, 30 Bond St, Toronto, ON, M5B 1W8, Canada. vermasu@smh.ca.
  • Mazer CD; Department of Anesthesia, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Fitchett D; Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA.
  • Pfarr E; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
  • George JT; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Zinman B; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
Diabetologia ; 61(8): 1712-1723, 2018 08.
Article in En | MEDLINE | ID: mdl-29777264
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzhydryl Compounds / Cardiovascular Diseases / Coronary Artery Bypass / Glucosides / Heart Failure / Kidney Diseases Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzhydryl Compounds / Cardiovascular Diseases / Coronary Artery Bypass / Glucosides / Heart Failure / Kidney Diseases Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article